AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding AC Immune SA changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 37 | 34 | −3 |
| Shares | 14.8M | 14.1M | −664.0K (−4.5%) |
| Value | $30.1M | $33.0M | +$2.88M (+9.5%) |
New holders (5)
Institutions that held AC Immune SA at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 870,179 | $2.04M | 0.00% |
| Dimensional Fund Advisors LP | 46,247 | $108.2K | 0.00% |
| Acadian Asset Management LLC | 3,845 | $8.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 3,400 | $7.96K | 0.00% |
| Tower Research Capital LLC (TRC) | 553 | $1.00K | 0.00% |
Sold out (8)
Institutions that held AC Immune SA at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Artal Group S.A. | 1,000,000 | $2.04M |
| Jane Street Group, LLC | 42,581 | $86.9K |
| Virtu Financial LLC | 35,501 | $72.0K |
| Cubist Systematic Strategies, LLC | 21,384 | $43.6K |
| Goldman Sachs Group Inc | 18,867 | $38.5K |
| Simplex Trading, LLC | 4,036 | $8.00K |
| BNP Paribas Arbitrage, SA | 901 | $1.84K |
| Bank of America Corp | 10 | $20 |